Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab-Reference-Cited by-同舟云学术

Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab

Published:2012-05-06 Issue:12 Volume:71 Page:1955-1960
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Plasencia Chamaida,Pascual-Salcedo Dora,Nuño Laura,Bonilla Gema,Villalba Alejandro,Peiteado Diana,Díez Jesús,Nagore Daniel,del Agua Ainhoa Ruiz,Moral Rosario,Martin-Mola Emilio,Balsa Alejandro

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No Correlation between Anti-drug Antibodies and Therapeutic Response in Tunisian Patients with Chronic Inflammatory Diseases Treated by TNF Blockers;Current Rheumatology Reviews;2024-09

2. Long‐Term Follow‐Up of Anti‐Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and Tapering;Arthritis & Rheumatology;2024-07-14

3. Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials;The Lancet Rheumatology;2024-04

4. Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases;Rheumatology;2024-01-04

5. High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis;Arthritis Research & Therapy;2023-10-17